Alembic Pharmaceuticals
- Advice
- Hold
Alembic Pharmaceuticals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Alembic Pharmaceuticals
Start SIPAlembic Pharmaceuticals Investment Rating
-
Master Rating:
-
Alembic Pharmaceuticals has an operating revenue of Rs. 5,661.91 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of 12% is healthy, ROE of 9% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 32 which is a POOR score indicating inconsistency in earnings, a RS Rating of 19 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 1,310 | 1,354 | 1,160 | 1,304 |
| Operating Expenses Qtr Cr | 1,086 | 1,109 | 1,034 | 1,013 |
| Operating Profit Qtr Cr | 224 | 245 | 127 | 291 |
| Depreciation Qtr Cr | 66 | 67 | 46 | 46 |
| Interest Qtr Cr | 15 | 12 | 9 | 6 |
| Tax Qtr Cr | 25 | 21 | 0 | 0 |
| Net Profit Qtr Cr | 119 | 146 | 72 | 251 |
Alembic Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 7
- Bearish Moving Average
- ___
- 9
- 20 Day
- 492.81
- 50 Day
- 513.6
- 100 Day
- 544.32
- 200 Day
- 595.68
- 20 Day
- 492.36
- 50 Day
- 513.93
- 100 Day
- 553.04
- 200 Day
- 603.98
Alembic Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 480.2 |
| Second Resistance | 491.75 |
| Third Resistance | 500.7 |
| RSI | 49.41 |
| MFI | 61.8 |
| MACD Single Line | -10.14 |
| MACD | -9.14 |
| Support | |
|---|---|
| First Resistance | 459.7 |
| Second Resistance | 450.75 |
| Third Resistance | 439.2 |
Alembic Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 1,160,304 | 11,254,949 | 9.7 |
| Week | 434,367 | 12,453,302 | 28.67 |
| 1 Month | 187,094 | 6,318,147 | 33.77 |
| 6 Month | 157,938 | 7,745,288 | 49.04 |
Alembic Pharmaceuticals Result Highlights
Alembic Pharmaceuticals Synopsis
NSE-Medical-Generic Drugs
Alembic Pharmaceutic is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 5035.41 Cr. and Equity Capital is Rs. 39.31 Cr. for the Year ended 31/03/2022. Alembic Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/06/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2010PLC061123 and registration number is 061123.| Market Cap | 9,687 |
| Sales | 5,129 |
| Shares in Float | 5.90 |
| No of funds | 164 |
| Yield | 2.13 |
| Book Value | 1.83 |
| U/D Vol ratio | 1.1 |
| LTDebt / Equity | 4 |
| Alpha | -0.18 |
| Beta | 0.5 |
Alembic Pharmaceuticals
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 69.61% | 69.61% | 69.61% | |
| Mutual Funds | 5.87% | 5.36% | 5.01% | |
| Insurance Companies | 6.6% | 7.03% | 7.01% | |
| Foreign Portfolio Investors | 4.99% | 5.32% | 5.94% | |
| Financial Institutions/ Banks | 0.04% | 0.04% | 0.04% | |
| Individual Investors | 9.21% | 9.12% | 8.91% | |
| Others | 3.68% | 3.52% | 3.48% |
Alembic Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Chirayu Amin | Chairman & CEO |
| Mr. Pranav Amin | Managing Director |
| Mr. Shaunak Amin | Managing Director |
| Mr. R K Baheti | Director - Finance & CFO |
| Mr. K G Ramanathan | Independent Director |
| Mr. Pranav Parikh | Independent Director |
| Mr. Paresh Saraiya | Independent Director |
| Dr. Archana Hingorani | Independent Director |
| Mr. Ashok Barat | Independent Director |
Alembic Pharmaceuticals Forecast
Price Estimates
Alembic Pharmaceuticals FAQs
What is Share Price of Alembic Pharmaceuticals ?
Alembic Pharmaceuticals share price is ₹496 As on 31 March, 2023 | 20:24
What is the Market Cap of Alembic Pharmaceuticals ?
The Market Cap of Alembic Pharmaceuticals is ₹9756.4 Cr As on 31 March, 2023 | 20:24
What is the P/E ratio of Alembic Pharmaceuticals ?
The P/E ratio of Alembic Pharmaceuticals is 43.4 As on 31 March, 2023 | 20:24
What is the PB ratio of Alembic Pharmaceuticals ?
The PB ratio of Alembic Pharmaceuticals is 1.9 As on 31 March, 2023 | 20:24